BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25659450)

  • 1. Cardioprotective effect of valsartan in mice with short-term high-salt diet by regulating cardiac aquaporin 1 and angiogenic factor expression.
    Jiang Y; Wang HY; Zheng S; Mu SQ; Ma MN; Xie X; Zhang YY; Zhang CX; Cai JH
    Cardiovasc Pathol; 2015; 24(4):224-9. PubMed ID: 25659450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
    Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload.
    Ito K; Hirooka Y; Sunagawa K
    Circ Res; 2009 Apr; 104(8):1004-11. PubMed ID: 19299647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats.
    Mercier N; Labat C; Louis H; Cattan V; Benetos A; Safar ME; Lacolley P
    Am J Hypertens; 2007 Mar; 20(3):319-25. PubMed ID: 17324746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
    Leelahavanichkul A; Yan Q; Hu X; Eisner C; Huang Y; Chen R; Mizel D; Zhou H; Wright EC; Kopp JB; Schnermann J; Yuen PS; Star RA
    Kidney Int; 2010 Dec; 78(11):1136-53. PubMed ID: 20736988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
    Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
    J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
    Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt-induced downregulation of renal aquaporins is prevented by losartan.
    Della Penna SL; Cao G; Fellet A; Balaszczuk AM; Zotta E; Cerrudo C; Pandolfo M; Toblli JE; Fernández BE; Rosón MI
    Regul Pept; 2012 Aug; 177(1-3):85-91. PubMed ID: 22587908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension.
    Zhang X; Yang X; Lin Y; Suo M; Gong L; Chen J; Hui R
    Int J Clin Exp Pathol; 2015; 8(6):6981-7. PubMed ID: 26261587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension.
    Yamada Y; Tsuboi K; Hattori T; Murase T; Ohtake M; Furukawa M; Ueyama J; Nishiyama A; Murohara T; Nagata K
    Hypertens Res; 2011 Jul; 34(7):809-16. PubMed ID: 21471973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial hypertrophy induced by high salt consumption is prevented by angiotensin II AT2 receptor agonist.
    Dopona EPB; Rocha VF; Furukawa LNS; Oliveira IB; Heimann JC
    Nutr Metab Cardiovasc Dis; 2019 Mar; 29(3):301-305. PubMed ID: 30642787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.